French quantum computing firm Pasqal is going public via a SPAC merger with Bleichroeder Acquisition Corp. II at a $2 billion pre-money valuation. The transaction is expected to provide over $600 million in gross proceeds, sourced from the SPAC trust, convertible financing, and Pasqal’s balance sheet. The deal allows Pasqal to fund its neutral atom technology roadmap and accelerate commercialization with partners like IBM and NVIDIA. This transaction validates the SPAC vehicle as a rapid path to U.S. public markets for capital-intensive, European deep-tech companies.
- Target
- Pasqal Holding SAS
- Acquirer
- Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ)
- Transaction Type
- SPAC Business Combination
- Pre-Money Valuation
- $2.0 Billion
- Projected Gross Proceeds
- Over $600 million (contingent on minimal redemptions)
- Committed Convertible Financing
- $200 Million
- SPAC Trust Account
- Approximately $289 million
- Target’s Cash on Hand
- Approximately $158 million
- Key Investors
- Inflection Point, BPIfrance Large Venture
- Target Listing Exchange
- Nasdaq
- Expected Closing
- H2 2026
- Key Technology
- Neutral atom quantum computing
NEW YORK & PARIS — March 4, 2026
Pasqal Holding SAS, the French quantum computing firm known for its neutral atom technology, is set to transition to the public markets via a definitive business combination agreement with Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ), a special purpose acquisition company (SPAC). The transaction values the combined entity, which will operate as Pasqal, at a $2 billion pre-money valuation, signaling robust, albeit speculative, confidence in the commercial viability of high-performance quantum hardware.
Most “AI for Diligence” tools are lying to you. The truth is, they are just ChatGPT wrappers. Experience what real AI for Diligence looks like, built like Claude Code, but for M&A/ PE Diligence:
💼 When Claude Code Marries Due Diligence!
This move places Pasqal among a growing cohort of quantum pure-plays—including recent entrants like Infleqtion and planned listings such as Xanadu—that are leveraging the SPAC structure to gain rapid access to U.S. capital markets. For deal advisors and private equity sponsors monitoring quantum technology investment strategies, this exit pathway validates the SPAC vehicle for deep-tech companies seeking immediate public currency.
Strategic Capital Infusion and Deal Mechanics
The proposed merger is structured to deliver significant liquidity and fuel Pasqal’s aggressive roadmap. The transaction is anticipated to provide Pasqal with more than $600 million in gross proceeds, contingent upon minimal shareholder redemptions.
This inflow comprises several tranches:
- Approximately $289 million from Bleichroeder’s trust account (as of February 28, 2026).
- $200 million in committed convertible financing, anchored by sponsor-affiliated investor Inflection Point and existing backer BPIfrance Large Venture.
- Approximately $158 million in cash already on Pasqal’s balance sheet as of the same date.
The deal is spearheaded by a SPAC management team including Co-Founders Michel Combes and Andrew Gundlach. Bleichroeder itself only recently completed its own IPO in January 2026, raising $287.5 million.
The Neutral Atom Advantage in the Qubit Race
Pasqal differentiates itself through its core technology: neutral atom quantum computing. Unlike superconducting or trapped-ion rivals, this modality—which employs individual atoms trapped by lasers—is championed for its superior scaling potential and flexible qubit arrangements.
The company claims significant operational milestones, having deployed seven quantum computers with three more currently in production. Crucially, Pasqal highlights key industrial endorsements, including partnerships with tech giants like IBM (as part of the IBM Quantum Network) and NVIDIA, alongside major clients such as Sumitomo, CMA CGM, and Thales.
Pasqal reported significant top-line momentum ahead of the announcement, citing approximately 100% revenue growth in 2025 (unaudited) and approximately $80 million in booked and awarded business, including grants.
This infusion of capital is explicitly intended to accelerate the demonstration of “quantum advantage,” push toward fault-tolerant architectures, and execute on international growth strategies, positioning the company to capitalize on projections suggesting quantum computing could unlock up to $850 billion in annual value by 2040.
Deal Snapshot: Pasqal/BBCQ Business Combination
| Metric | Value |
|---|---|
| Pre-Money Valuation | $2.0 Billion |
| Committed Convertible Financing | $200 Million |
| Projected Gross Proceeds (Assumes No Redemptions) | >$600 Million |
| Target Listing Exchange | Nasdaq |
| Expected Closing Timeline | H2 2026 |
Source: Public Filings, WSJ Analysis of Deal Terms.
Implications for Quantum Public Market Access
The announcement comes amid increased public market differentiation among quantum modalities. With other firms recently entering the public domain via SPACs—notably IonQ (trapped ion), Infleqtion (neutral atom), and Xanadu (photonic)—investors are gaining granular exposure to competing technological pathways.
For legal and financial counsel specializing in cross-border M&A transactions and technology listings, the Pasqal deal serves as a crucial case study in balancing the speed of the SPAC route against the thorough due diligence required for complex, capital-intensive deep-tech platforms. The successful financing anchor by BPIfrance Large Venture underscores continued European sovereign support for strategic technology champions transitioning to global scale.
The transaction is subject to customary closing conditions, including regulatory and shareholder approvals, with an expected public debut in the latter half of 2026. The success of this listing will be closely watched for signals regarding investor appetite for high-risk, high-reward post-hype quantum public offerings.
Sources
investing.com businesswire.com substack.com cohencm.com quiverquant.com investing.com techfundingnews.com pasqal.com
